CFN Media’s Exclusive Interview with Aleafia Health CEO Geoffrey Benic Discussing Emblem Corp. Acquisition
January 22nd, 2019
Exclusive, News, Top Story
CFN Media recently sat down with Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH) CEO Geoffrey Benic to discuss the company’s acquisition of Emblem Corp. (TSX-V: EMC) (OTCQX: EMMBF) creating Canada’s largest cannabis clinic network along with 138,000 kilograms per year of planned annual cultivation capacity—making it an overnight leader in the medical side of the nascent cannabis industry.
CFN Media: Why did you initially decide to focus on medical clinics?
Geoffrey Benic: A question we continuously ask ourselves at Aleafia Health is “how will this our accelerate our business strategy?” What the acquisition of Canabo did was leverage their tremendous success in physician-led cannabis therapy, which is why they’ve treated over 50,000 patients. There is tremendous loyalty among our patients because of that direct contact with physicians. It is such a significant differentiator for us. Whereas most medical cannabis transactions involve purchasing products on a website, our patients benefit from direct contact with a physician they trust.
We have been able to make hugely impactful improvements to our patients’ well being, and in doing so, have garnered among the largest patient bases in the country, 10 million proprietary data points and clinic operations expertise which is immensely valuable for international partners.
CFN Media: Why did you decide to pursue the acquisition Emblem?
Geoffrey Benic: Widespread consolidation will occur across the industry with a handful of companies capturing the lion’s share of the market. We intend to be consolidator. But you must do so strategically, by acquiring companies with complementary assets and capabilities, along with excellent management. For us, that’s Emblem.
CFN Media: What are some of the immediate synergies that will be realized?
Geoffrey Benic: Case in point: Emblem has a robust product portfolio of medical cannabis products, including oils, capsules and sprays. And there is a major supply shortage of medical cannabis. We want to ensure that our patients have access to medicine, and we can only do that by controlling the entire supply chain. We have the cultivation, the clinics and the patients. Emblem brings the product expertise including extraction, processing and labelling to us on day one.
Click Here to Download Aleafia Health Inc.’s Investor Presentation
CFN Media: Can you discuss your cannabis production and distribution plans?
Geoffrey Benic: Upon the closing of the acquisition, we will boast a global distribution platform. Emblem has a highly coveted supply agreement with Shoppers Drug Mart, Canada’s largest pharmacy chain. They supply a top cannabis dispensary retailer, Fire and Flower, and their Joint-Venture with Acnos Pharma, a major German pharmaceutical wholesaler ensures access to pharmacies in the largest medical market in the world.
From Aleafia’s standpoint, we have a 15,000 kg supply agreement with CannTrust, along with retail and brands Joint-Ventures with Aaron Serruya and Serruya Private Equity. They have been an innovative, leading force in the cannabis industry, and have experience running global brands including Yogen Fruz.
CFN Media: What catalysts can investors look forward to over the coming months?
Geoffrey Benic: Aleafia Health is going to continue exploring strategic acquisitions. But the number one focus will be on successfully integrating Aleafia and Emblem into a cohesive business with operations across the entire value chain, from cannabis cultivation, to product development, to medical and recreational distribution.
Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH) is well positioned to become one of the largest and most diverse cannabis companies in the industry following its merger with Emblem Corp. With a leading network of medical cannabis clinics and 138,000 kilograms per year of production capacity, investors may want to keep a close eye on the stock as it grows its presence in medical and expands into recreational.
For more information, visit the company’s website
Click Here to Download Aleafia Health Inc.’s Investor Presentation.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.